Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2020
A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort StudyDominique L Braun, Benjamin Hampel, Bruno Ledergerber, et al.
Plos One|January 8, 2026
Association of leukocyte count with death in people with HIV: A longitudinal study over 24 yearsZoe Klein, Sophia C Meyer, Isabella C Schoepf, et al.
HIV Medicine|August 1, 2025
Leukocyte count and new-onset diabetes mellitus in people with HIV: A longitudinal studySophia C Meyer, Zoe Klein, Isabella C Schoepf, et al.
The Lancet. Healthy Longevity|May 6, 2023
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 yearsIsabella C Schoepf, Andrés Esteban-Cantos, Christian W Thorball, et al.
Nature Communications|January 19, 2020
Machine learning can identify newly diagnosed patients with CLL at high risk of infectionRudi Agius, Christian Brieghel, Michael A Andersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin ConcentrationsChristine Sekaggya-Wiltshire, Amrei von Braun, Mohammed Lamorde, et al.
Antiviral Therapy|September 13, 2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysisMassimo Puoti, Alessandro Cozzi-Lepri, Giuseppe Paraninfo, et al.
Lancet (London, England)|April 14, 2009
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies, Jonathan A C Sterne, Margaret May, et al.
International Journal of Epidemiology|November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristicsMargaret T May, Robert S Hogg, Amy C Justice, et al.
Lancet (London, England)|July 20, 2010
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study, Rebecca K Lodwick, Caroline A Sabin, et al.
Pageof 22